Lb Pharmaceuticals

LBRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.387 B

$42.99 +1.22%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$25.2M

Loss-making

Shares outstanding

32,259,175

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#137Latigo BiotherapeuticsLTGO$1.40B
#138First Tracks BiotherapeuticsTRAX$1.39B
#139Lb PharmaceuticalsLBRX$1.39B
#140OmerosOMER$1.34B
#141Oric PharmaceuticalsORIC$1.31B

What if Lb Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$938,463.37

Per share 21,830× higher

Bitcoin $1.72T

$53,312.08

Per share 1,240× higher

Nvidia $5.48T

$169,869.75

Per share 3,951× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Lb Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.